专利信息

首页 1 2 3 4 5 6 下页尾页共 125 条记录, 当前第1/13页。

专利标题：Monohydrate solvates of loracarbef

This invention relates to monohydrate solvates of loracarbef. The invention also relates to processes for preparing solvates of loracarbef, crystalline monohydrate of loracarbef from said solvates and pharmaceutical compositions that include the crystalline monohydrate of loracarbef.

专利标题：Monohydrate solvates of loracarbef

专利权人：RANBAXY LABORATORIES LIMITED;

This invention relates to monohydrate solvates of loracarbef. The invention also relates to processes for preparing solvates of loracarbef crystalline monohydrate of loracarbef from said solvates and pharmaceutical compositions that include the crystalline monohydrate of loracarbef.

专利标题：Monohydrate solvates of loracarbef

专利权人：RANBAXY LAB LTD [IN];

专利标题：MONOHYDRATE SOLVATES OF LORACARBEF

专利权人：RANBAXY LAB LTD [IN];

专利标题：Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate

专利权人：ELI LILLY AND COMPANY;

The invention is directed to the crystalline isopropyl alcohol solvate of loracarbef and also is directed to a process for the preparation of the crystalline monohydrate form of the compound of formula (I) which includes exposing the crystalline isopropyl solvate form of the compound of formula (I) to a temperature of between about 50.degree. and 90.degree.C and a relative humidity of between about 60 to about 100%.

专利标题：Process for converting loracarbef dihydrate to loracarbef monohydrate

专利权人：ELI LILLY AND COMPANY;

A process for the preparation of the crystalline monohydrate form of the compound of formula (I) (see formula I) which includes exposing the crystalline dehydrate form of the compound of formula (I) to a temperature of between about 50.degree. and 65.degree.C and a relative humidity of between about 60 to about 100%.

专利标题：MONOHYDRATE SOLVATES OF LORACARBEF

专利权人：RANBAXY LAB LTD;

专利标题：MONOHYDRATE SOLVATES OF LORACARBEF

专利权人：RANBAXY LAB LTD [IN];

专利标题：Antibiotics for treating biohazardous bacterial agents

The present invention is directed to methods for the control of strains of bio-hazardous bacterial agents. These agents include: Bacillus anthracis, Yersinia Pestis, Francisella tularensis, Clostridium botulinin, Clostridium Perfringens, Brucella abortis, B milletensis, B suis and Burkholderia mallei. These methods employ treating an infected warm-blooded animal with an antibiotics selected from: Cephalothin, Cefazolin, Cephalexin monohydrate, Cephalexin HCl, Cefaclor, Loracarbef, Erythromycin e...

当前查询条件: [药品] 包含 'Loracarbef '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US2006205938A1	2006/9/14	US20030535677	2003/11/21
专利标题：Monohydrate solvates of loracarbef 专利权人： This invention relates to monohydrate solvates of loracarbef. The invention also relates to processes for preparing solvates of loracarbef, crystalline monohydrate of loracarbef from said solvates and pharmaceutical compositions that include the crystalline monohydrate of loracarbef.

2. US20060205938A1	2006/9/14	US10/535677	2003/11/21
专利标题：Monohydrate solvates of loracarbef 专利权人：RANBAXY LABORATORIES LIMITED; This invention relates to monohydrate solvates of loracarbef. The invention also relates to processes for preparing solvates of loracarbef crystalline monohydrate of loracarbef from said solvates and pharmaceutical compositions that include the crystalline monohydrate of loracarbef.

3. CN1732167A	2006/2/8	CN20038107767	2003/11/21
专利标题：Monohydrate solvates of loracarbef 专利权人：RANBAXY LAB LTD [IN];

4. EP1565462A1	2005/8/24	EP20030775604	2003/11/21
专利标题：MONOHYDRATE SOLVATES OF LORACARBEF 专利权人：RANBAXY LAB LTD [IN];

5. CA2124999C	2004/8/10	CA19942124999	1994/6/2
专利标题：Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate 专利权人：ELI LILLY AND COMPANY; The invention is directed to the crystalline isopropyl alcohol solvate of loracarbef and also is directed to a process for the preparation of the crystalline monohydrate form of the compound of formula (I) which includes exposing the crystalline isopropyl solvate form of the compound of formula (I) to a temperature of between about 50.degree. and 90.degree.C and a relative humidity of between about 60 to about 100%.

6. CA2125001C	2004/8/3	CA19942125001	1994/6/2
专利标题：Process for converting loracarbef dihydrate to loracarbef monohydrate 专利权人：ELI LILLY AND COMPANY; A process for the preparation of the crystalline monohydrate form of the compound of formula (I) (see formula I) which includes exposing the crystalline dehydrate form of the compound of formula (I) to a temperature of between about 50.degree. and 65.degree.C and a relative humidity of between about 60 to about 100%.

7. AU2003283624A1	2004/6/15	AU20030283624	2003/11/21
专利标题：MONOHYDRATE SOLVATES OF LORACARBEF 专利权人：RANBAXY LAB LTD;

8. WO2004046142A1	2004/6/3	WO2003IB05331	2003/11/21
专利标题：MONOHYDRATE SOLVATES OF LORACARBEF 专利权人：RANBAXY LAB LTD [IN];KUMAR YATENDRA [IN];TEWARI NEERA [IN];MEERAN HASHIM NIZAR POOVANATHI [IN];RAI BISHWA PRAKASH [IN];SINGH SHAILENDRA KUMAR [IN]; This invention relates to monohydrate solvates of loracarbef. The invention also relates to processes for preparing solvates of loracarbef, crystalline monohydrate of loracarbef from said solvates and pharmaceutical compositions that include the crystalline monohydrate of loracarbef.

9. CA2506872A1	2004/6/3	CA20032506872	2003/11/21
专利标题：MONOHYDRATE SOLVATES OF LORACARBEF 专利权人：RANBAXY LAB LTD [IN]; This invention relates to monohydrate solvates of loracarbef. The invention also relates to processes for preparing solvates of loracarbef, crystalline monohydrate of loracarbef from said solvates and pharmaceutical compositions that include the crystalline monohydrate of loracarbef.

10. US2003176327A1	2003/9/18	US20020274692	2002/10/18
专利标题：Antibiotics for treating biohazardous bacterial agents 专利权人： The present invention is directed to methods for the control of strains of bio-hazardous bacterial agents. These agents include: Bacillus anthracis, Yersinia Pestis, Francisella tularensis, Clostridium botulinin, Clostridium Perfringens, Brucella abortis, B milletensis, B suis and Burkholderia mallei. These methods employ treating an infected warm-blooded animal with an antibiotics selected from: Cephalothin, Cefazolin, Cephalexin monohydrate, Cephalexin HCl, Cefaclor, Loracarbef, Erythromycin e...

下载范围

下载内容